Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05893810
What this trial is testing

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Who this might be right for
Nasopharyngeal CarcinomaRadiation-induced Oral MucositisBacterial Colonization+1 more
Jiangxi Provincial Cancer Hospital 176
Not applicableUnknownNCT03202173
What this trial is testing

The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy

Who this might be right for
Nasopharyngeal CarcinomaSquamous Cell Carcinoma of the Head and Neck
Eye & ENT Hospital of Fudan University 31
Not applicableLooking for participantsNCT05884983
What this trial is testing

Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 12,000
Not applicableActive Not RecruitingNCT02984410
What this trial is testing

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

Who this might be right for
Oropharyngeal CancerSupraglottic Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 112
Testing effectiveness (Phase 2)Study completedNCT00006361
What this trial is testing

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT00563927
What this trial is testing

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Who this might be right for
Nasopharyngeal NeoplasmsCarcinoma, Squamous Cell
Hospital Authority, Hong Kong 340
Not applicableLooking for participantsNCT07137052
What this trial is testing

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)PET / CT
The First Affiliated Hospital of Xiamen University 732
Testing effectiveness (Phase 2)Study completedNCT03906058
What this trial is testing

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Not applicableNot Yet RecruitingNCT03367884
What this trial is testing

Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer

Who this might be right for
Hypopharyngeal Carcinoma
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06445114
What this trial is testing

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CancerCarcinoma
Zachary Zumsteg 50
Early research (Phase 1)Study completedNCT00049166
What this trial is testing

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer

Who this might be right for
Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)Study completedNCT02562599
What this trial is testing

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Who this might be right for
Nasopharyngeal Carcinoma
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02523430
What this trial is testing

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fuda Cancer Hospital, Guangzhou 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797881
What this trial is testing

BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07277764
What this trial is testing

Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Recurrent Nasopharyngeal Neoplasms
Jiangxi Provincial Cancer Hospital 23
Testing effectiveness (Phase 2)UnknownNCT04072107
What this trial is testing

EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 110
Not applicableUnknownNCT02627807
What this trial is testing

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 386
Large-scale testing (Phase 3)UnknownNCT02958111
What this trial is testing

Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 406
Not applicableUnknownNCT06301672
What this trial is testing

Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders

Who this might be right for
Dysphagia
Muhammad 60
Next Page